Skip to main content
The Cell Surface logoLink to The Cell Surface
. 2020 Aug 5;6:100043. doi: 10.1016/j.tcsw.2020.100043

Biofilms of the non-tuberculous Mycobacterium chelonae form an extracellular matrix and display distinct expression patterns

Perla Vega-Dominguez a, Eliza Peterson b, Min Pan b, Alessandro Di Maio a, Saumya Singh c, Siva Umapathy c, Deepak K Saini d, Nitin Baliga b, Apoorva Bhatt a,
PMCID: PMC7421604  PMID: 32803022

Abstract

Mycobacterium chelonae is an environmental, non-tuberculous mycobacterial species, capable of causing infections in humans. Biofilm formation is a key strategy used by M. chelonae in colonising niches in the environment and in the host. We studied a water-air interface (pellicle) biofilm of M. chelonae using a wide array of approaches to outline the molecular structure and composition of the biofilm. Scanning electron micrographs showed that M. chelonae biofilms produced an extracellular matrix. Using a combination of biochemical analysis, Raman spectroscopy, and fluorescence microscopy, we showed the matrix to consist of proteins, carbohydrates, lipids and eDNA. Glucose was the predominant sugar present in the biofilm matrix, and its relative abundance decreased in late (established) biofilms. RNA-seq analysis of the biofilms showed upregulation of genes involved in redox metabolism. Additionally, genes involved in mycolic acid, other lipid and glyoxylate metabolism were also upregulated in the early biofilms.

Abbreviations: NTMs, Non-tuberculous mycobacteria; ECM, Extracellular matrix; SEM, Scanning electron microscopy; DEG, Differentially expressed genes; eDNA, Extra cellular DNA; FMA, Free mycolic acids; TDM, Trehalose dimycolate; PG, Phosphatidyl glycerol

Keywords: Non-tuberculous mycobacteria, Mycobacterium chelonae, Biofilms, Extracellular matrix, Raman spectroscopy, Lipids

1. Introduction

Bacteria belonging to the genus Mycobacterium are predominantly environmental species, though some have evolved to become human and animal pathogens, including the causative agents of tuberculosis and leprosy (Bottai et al., 2014). A group of mycobacteria, termed non-tuberculous mycobacteria (NTMs), are capable of a dual lifestyle, usually occupying an environmental niche, but can cause a broad range of infections in humans (Falkinham, 2013). These include Mycobacterium fortuitum, and subspecies of the Mycobacterium avium complex (MAC) and Mycobacterium abscessus complex that cause pulmonary infections, and Mycobacterium chelonae, Mycobacterium marinum and Mycobacterium ulcerans that infect skin and soft tissue. In particular the members of the MAC are associated with HIV mortality (Corti and Palmero, 2008) and M. abscessus is often identified in the lungs of cystic fibrosis patients (Jönsson et al., 2007, Qvist et al., 2013). A key strategy for colonisation of both environmental and host niches by NTMs is the formation of biofilms (Falkinham, 2009). In the environment, NTM biofilms are found in water bodies including lakes, rivers and streams (De Groote et al., 2006, Iivanainen et al., 2010). The journey from the environment to host can also take place via intermediary or ‘man-made’ niches which includes tubing in hospital equipment, catheters, and plumbing for residential water supply (Falkinham, 2009). NTM biofilms in an infected host (Holland et al., 2017, Qvist et al., 2013, Qvist et al., 2015) are likely to play a key role in virulence (Faria et al., 2015), either by easing the colonization of the human host, evading the immune response, and/or fostering bacilli with an increased drug-tolerant phenotype (Aung et al., 2017, Aung et al., 2016, Davidson et al., 2011, Falkinham, 2009, Nessar et al., 2011, Orme and Ordway, 2014, Rhoades et al., 2019, Roux et al., 2016). Biofilms of NTMs can also act as reservoirs to seed bacteria into hosts (Benwill and Wallace, 2014, Gilbert, 2017, Jeon, 2019, Schreiber et al., 2018).

A number of mycobacterial species are known to forms biofilms in nature or in vitro (Chakraborty and Kumar, 2019, Zambrano and Kolter, 2005), and while some mycobacterial biofilm-associated phenotypes and components are common, other characteristics are species specific (Chakraborty and Kumar, 2019). An example of both can be found in the distinct lipids found in the mycobacterial cell envelope. Many mycobacterial biofilms accumulate free mycolic acids (FMA) (Ojha et al., 2010, Ojha et al., 2008, Sambandan et al., 2013) which form part of an extracellular matrix, and in M. smegmatis FMAs are released by enzymatic hydrolysis of trehalose dimycolate (TDM) by a cutinase-like serine esterase encoded by MSMEG_1529 (Ojha et al., 2010). Both M. smegmatis and M. tuberculosis produce three subclasses of mycolic acids, of which the α-mycolates are found in both. Additionally M. smegmatis synthesises α’ and epoxy mycolates, while M. tuberculosis makes the oxygenated mycolates-methoxy and keto mycolic acids. Interestingly, keto mycolic acids, absent in M. smegmatis and other mycobacteria including NTMs, are also essential for biofilm formation in M. tuberculosis (Sambandan et al., 2013). Furthermore, glycopeptidolipids from the MAC and M. smegmatis play a key role in biofilm formation in these species (Freeman et al., 2006, Nessar et al., 2011, Recht and Kolter, 2001), but are not produced by other mycobacteria including members of the Mycobacterium tuberculosis complex.

Mycobacterium chelonae is an NTM that causes skin and soft tissue infections and is also the leading cause of mycobacterial ocular infections (Kheir et al., 2015). While M. chelonae has been often characterised as an opportunistic pathogen, causing infections in immunocompromised hosts who have undergone trauma or iatrogenic procedures, it has also been reported to infect individuals with no underlying immune deficiencies (Campbell et al., 2013, Jagadeesan et al., 2013). In this study we chose to study biofilms of M. chelonae for a number of reasons. First, M. chelonae is a rapid biofilm former and can form biofilms under a range of nutrient proficiencies (Hall-Stoodley et al., 1999). Next, across a range of niches, ranging from water bodies, medical equipment and catheters, to diverse infected regions in a host, including skin, cornea and implants, biofilm formation is a key strategy for M. chelonae colonisation (Falkinham, 2009, Martín-de-Hijas et al., 2009). Unlike a lot of other mycobacteria, M. chelonae has been shown to form biofilms in vivo (Aung et al., 2017, Chandra et al., 2001). And finally, M. chelonae is regarded as a highly drug tolerant NTM (Brown-Elliott et al., 2012, Cowman et al., 2016), attributed in part to the presence of strains with decreased expression of porins (Garcia et al., 2019, Svetlíková et al., 2009), as well as the presence of beta lactamases (Kwon et al., 1995) encoded in its genome (Fedrizzi et al., 2017), properties which potentially make it difficult to treat infections that involve biofilms of M. chelonae. Despite the importance of biofilms in the pathobiology of M. chelonae, we do not have a good understanding of how this NTM species forms biofilms, what they are composed of, and if they differ in composition to those of other mycobacteria.

Deciphering biofilm formation in M. chelonae not only sheds light on our understanding of mycobacterial biofilm formation in general, but also has implications for future therapies that combine strategies to weaken these structures in addition to standard antimicrobial regimes when treating NTM infections. In this study we aimed to study the molecular components of M. chelonae pellicles, a water-air interphase biofilm, using an array of approaches that use electron microscopy, confocal microscopy, Raman spectroscopy and other analytical methods to define its ultrastructure, and biochemical content. Furthermore, we used transcriptomics to outline distinct expression patterns in the pellicles compared to planktonic cultures, enabling us to conduct future studies outlining the temporal mechanisms of biofilm establishment and formation.

2. Materials and methods

2.1. Culture conditions

M. chelonae CCUG47445 was routinely grown in Middlebrook 7H9 (DifcoTM) supplemented with OADC (Oleic acid-Albumin-Dextrose-Catalase, BD DifcoTM) and 0.05% tyloxapol (Sigma-Aldrich) or 7H10 (DifcoTM) supplemented with OADC (BD DifcoTM) at 30 °C. For pellicle formation, logarithmic cultures (OD 0.8–1) were diluted in Sauton’s media supplemented with 0.5% glucose (Sigma), until an OD of 0.03, and growth in either on 24-well plates (for microscopy and lipid analysis) or on 75 cm2 cap-vented culture flasks (for transcriptomics and carbohydrate analysis), in a 30 °C static incubator for 5 (Biofilm t1) or 10 days (Biofilm t2). These specific time points were selected to capture two key transitions in M. chelonae biofilm formation, one occurring early (Biofilm t1) and linked to characteristic wrinkling of a mature mycobacterial pellicle. The second time point (Biofilm t2) aligned with a later event where the pellicular structure had sunk and was easily dispersed on agitation. For growing planktonic cultures, M. chelonae was inoculated in the same way as for pellicles, but tyloxapol was added to the cultures to a final concentration of 0.05%, and incubated at 100 rpm until an OD of 1.

2.2. RNA-Seq analysis

Biofilms (timepoint 1 and 2) and planktonic cultures from four different experiments were used for whole transcriptomics analysis. Total RNA was extracted from a 200 μL bacterial pellet, either from biofilms or planktonic bacteria. The bacterial pellets were resuspended in a lysis tube with 600 μL of a lysozyme (Amersham Pharmacia Biotec) solution (5 mg/mL in Tris-EDTA pH = 8, Thermo Fisher scientific) and 7 μL of β-mercaptoethanol (Sigma-Aldrich), and agitated at maximum speed in a FastPrep 120 Homogenizer (QBiogene) for one minute at room temperature. Following agitation, 60 μL of 10% sodium dodecyl sulfate (Sigma-Aldrich) were added to the mix, and the samples were homogenized at the same speed for two more minutes. To the recovered supernatant (600 μL), 60 μL of 3 M sodium acetate pH = 5.2 (Sigma-Aldrich) was added, followed by 720 μL of acid phenol pH = 4.2 (Fisher Bioreagents). After a five-minute incubation at 65 °C, the upper aqueous phase was recovered and washed once with 720 μL of acid phenol pH = 4.2, and once with 550 μL of chloroform/isoamyl alcohol 24:1 (Sigma-Aldrich). 400 μL of the recovered upper aqueous phase were mixed with 40 μL of 3 M sodium acetate pH = 5.2, followed by 3 volumes of chilled ethanol (Sigma-Aldrich). The RNA was precipitated overnight at 4 °C, and the obtained pellet was washed once with 70% ethanol. Once dry, the RNA pellet was resuspended in RNAse free water (Thermo Fisher Scientific), followed by a treatment with DNAse (Promega). The resulting RNA was quantified in the NanoDrop (Thermo Scientific), and its integrity was assessed in a 2100 Bioanalyzer system (Agilent Technologies).

The ribosomal RNA was depleted using the Ribo-Zero Gold rRNA Removal Kit (Illumina) according to the manufacturer directions. For synthesizing the DNA library, the Tru-Seq Stranded RNA (Illumina) and the samples were sequenced using an Illumina NextSeq Instrument. Paired-end 75 bp reads were checked for technical artifacts using Illumina default quality filtering steps. Raw FASTQ read data were processed using the R package DuffyNGS as described previously (Vignali et al., 2011). Briefly, raw reads were passed through a 3-stage alignment pipeline: (i) a prealignment stage to filter out unwanted transcripts, such as rRNA, mitochondrial RNA, albumin, and globin; (ii) a main genomic alignment stage against the genome(s) of interest. Reads were aligned to M. chelonae (ASM163280) with Bowtie2 (Langmead and Salzberg, 2012), using the command line option “very-sensitive.” No mitochondrial RNA, albumin, and globin genomes were provided for the bacterial samples. BAM files from stage (ii) was combined into read depth wiggle tracks that recorded both uniquely mapped and multiply mapped reads to each of the forward and reverse strands of the genome(s) at single-nucleotide resolution. Gene transcript abundance was then measured by summing total reads landing inside annotated gene boundaries, expressed as both RPKM and raw read counts. RNA-seq data (raw fastq files and read counts) have been deposited in the GEO repository under accession number GSE144514.

2.3. Differentially expressed genes

A panel of 5 differential expression (DE) analysis tools was used to identify gene expression changes between 5-day old biofilms (Biofilm t1) samples and planktonic samples or 10-day old biofilms (Biofilm t2) samples and planktonic samples. The tools included (i) RoundRobin (in-house); (ii) RankProduct (Breitling et al., 2004); (iii) significance analysis of microarrays (SAM) (Tusher et al., 2001); (iv) EdgeR (Robinson and Smyth, 2008); and (v) DESeq2 (Love et al., 2014). Each DE tool was called with appropriate default parameters and operated on the same set of transcription results, using RPKM abundance units for RoundRobin, RankProduct, and SAM and raw read count abundance units for DESeq2 and EdgeR. All 5 DE results were then synthesized, by combining gene DE rank positions across all 5 DE tools. Specifically, a gene’s rank position in all 5 results was averaged, using a generalized mean to the 1/2 power, to yield the gene’s final net rank position. Each DE tool’s explicit measurements of differential expression (fold change) and significance (P-value) were similarly combined via appropriate averaging (arithmetic and geometric mean, respectively). Genes with averaged absolute log2 fold change bigger than two and multiple hypothesis adjusted P-value below 0.01 were considered differentially expressed.

2.4. Analysis for metabolic pathway enrichment

We mapped the significantly differentially expressed genes at biofilm t1 and t2 against the most recent genome-scale metabolic network construction of M. tuberculosis H37Rv iEK1011 (Kavvas et al., 2018) by identifying orthologs using protein to protein sequence comparison using the BLOSUM62 scoring matrix (Henikoff and Henikoff, 1992). We used the subsystem definitions outlined in iEK1011 to explore pathway usage at the network level. We identified metabolic pathways that were significantly enriched in the M. chelonae biofilm stages (Benjamini Hochberg corrected hypergeometric P-value < 0.05). For these pathways, we calculated the average fold-change of all genes.

2.5. Raman spectroscopy

Raman spectra were collected from M. chelonae planktonic bacteria and biofilms (timepoint 1 and 2) using a Renishaw InVia Raman Microscope (Renishaw, UK) equipped with 785 nm laser. The laser was focussed onto the sample using a 50X objective with 0.75NA (Leica, Germany). Spectral calibration was performed using the 520.5 cm−1 Raman band for silicon. The laser power on the sample was 12 mW. Data collection was performed using the Wire 4.2 software with 8 s exposures and 10 accumulations.

The planktonic and biofilm bacterial cultures from each replicate (4 replicates) was pelleted (6000 X g, 4 °C, thrice) and resuspended in milliQ water. A concentrated bacterial solution of 2.5 µL was cast on MgF2 substrate (Global optics, UK). From each dried drop at least 30 spectra per experiment were collected from different areas of sample and each experiment was repeated thrice to account for biological heterogeneity.

Raman spectra were subjected to pre-processing steps. The spectra were checked for cosmic ray removal and baseline correction. All spectra were vector normalised to remove any effects related to concentration and instrumental variations using Origin 2016. To remove noise, the spectra were smoothened using 7 point, 3rd order polynomial -based analysis Savitzky- Golay smoothening using Wire 4.2. Multivariate analysis (PCA) were performed using Unscrambler X 10.3 (Camo Analytics, Norway).

To determine the main Raman shifts driving the variability between the samples, we applied a Principal Component Analysis in the normalized samples, using the SciKit-Learn (Pedregosa et al., 2011) module in Python, and we further associated the obtained Raman shifts with characteristic biomolecules as described before (Kuhar et al., 2018, Talari et al., 2015, Wiercigroch et al., 2017). The intensities between samples were compared using a Mann-Whitney u test, where the intensities of the samples were considered significantly different if the p-value < 0.05.

2.6. Scanning electron microscopy (SEM)

M. chelonae 5-day old biofilms (t1) were formed in a 24-well plate. 10-day old pellicles were easily disrupted due to movement, thus were not imaged. The formed biofilm was fixed overnight with a solution of 6% paraformaldehyde (Sigma Aldrich) in PBS, and imaged using a Philips XL-30 FEG ESEM in the Centre for Electron Microscopy at the University of Birmingham.

2.7. Confocal microscopy

eGFP-expressing M. chelonae biofilms t1 were formed as described for SEM, and stained with a single fluorophore targeting a specific component of the biofilm matrix. The conditions used for each fluorophore are summarized in Table 1. The stained pellicles then were fixed using paraformaldehyde 4% in PBS for 30 min, and mounted in microscope glass slides for further image acquisition. From three different experiments, five confocal z-stacks (covering approximately 4 μm) were acquired from each experimental sample. Images were acquired using a Nikon A1R system equipped with Ti microscope frame and a 100x/1.4 PlanApo objective.

Table 1.

Fluorophores and conditions used for staining M. chelonae biofilms for CLSM.

Fluorophore Target Concentration Time
Nile Red Lipids 1 μM 30 min
Propidium iodide Nucleic acids 15 μM 15 min
Sypro Ruby Proteins As provided by the manufacturer. 30 min
Alexa Fluor α-mannose and α-glucose in the pyranose configuration. 100 μg/mL 30 min

2.8. Image processing

The acquired images (5 images per each experiment, 3 different experiments) were processed in Icy software (de Chaumont et al., 2012), using a similar approach as in Pike et al., 2017. Briefly, the acquired images were de-noised using a median filter, and for generating the region of interest, an automated threshold was calculated using the Li method (Li and Tam, 1998). Once the region of interest (ROI) was created, the Colocalization Studio plugin and the ROI Statistics plugins in Icy were used to calculate the Pearson’s and Mander’s coefficients, and the volumes of the matrix components respectively.

2.9. Lipid analysis

For lipid analysis, M. chelonae biofilms and planktonic cultures were grown as described before, but Sauton’s media was supplemented with 14[C]-acetic acid (1 μCi/mL, Perkin Elmer). Different lipid fractions were extracted and resolved by thin layer chromatography as described previously (Besra, 1998). Lipid species were visualised by autoradiography by exposing X-ray films Kodak Carestream) to the resolved TLC plates for 48 h.

2.10. Extraction and analysis of surface exposed carbohydrates

Surface exposed materials were extracted mechanically as described elsewhere (Grzegorzewicz and Jackson, 2013, Parish et al., 2003). The harvested pellets from three different experiments of planktonic cultures and biofilms were mixed with 4 mm glass beads and shaken gently for 2 min, and immediately after, the pellets were resuspended in 50 mL of miliQ water, and further centrifuged at 3000g for 15 min at 4 °C. The obtained supernatants were filtered through a 0.45 μm pore size filter, and concentrated to 1/10th of the original volume using a rotary evaporator (Buchi). The concentrated filtrate was mixed with chloroform and methanol to a final ratio chloroform/methanol/water 1:2:0.8 (v/v/v). The mix was agitated for 1 h, and then centrifuged for 10 min at 3000g. The aqueous phase and the interphase were recovered in separate tubes. The interphase was re-extracted three more times with miliQ water and the obtained supernatants were pooled with the previously recovered aqueous phase. The pooled extracts were concentrated to a final volume of 2 mL of miliQ water for further digestion with Proteinase K (Promega). The protein-digested material was dialyzed against MiliQ water for 48 h using a 3.5 kDa SpectralPore dialysis membrane (Spectrum Laboratories Inc.), and 10 μL of the obtained materials were hydrolysed with trifluoroacetic acid (Sigma-Aldrich) to obtain monosaccharides for further derivatization of alditol acetates for gas chromatography analysis as described previously (Grzegorzewicz and Jackson, 2013).

3. Results

3.1. Scanning electron microscopy (SEM) reveals the presence of a potential extracellular matrix (ECM) in M. Chelonae biofilms.

To visualise the detailed ultrastructure of M. chelonae biofilms, we first imaged a 5-day old biofilm (Biofilm t1) by SEM. The micrographs revealed the presence of a thick material covering mycobacterial growth, likely an extracellular matrix (ECM), with no clear outlines of individual bacterial cells within the pellicle (Fig. 1B–D). SEMs of planktonic cultures, on the other hand revealed individual mycobacterial cells (Fig. 1A), lacking any discernible extracellular material. The M. chelonae biofilm also revealed the presence of pores intermingled with cords of M. chelonae, suggesting a similar architecture to biofilms of other mycobacterial species (Fig. 1C–D) (Bardouniotis et al., 2001, Marsollier et al., 2007, Sambandan et al., 2013, Trivedi et al., 2016). Thus, the one remarkable characteristic revealed by SEM was the presence of a substantial ECM in the M. chelonae biofilm. The pores observed in the biofilm were likely conduits for nutrients to inner parts of the biofilm.

Fig. 1.

Fig. 1

Scanning electron micrographs (SEMs) of M. chelonae cultures grown in Sauton’s media. Unlike planktonic M. chelonae where individual bacilli are clearly visible as rods (A), SEMs of 5-day old M. chelonae pellicles show the presence of contiguous mass of what appeared to be extracellular material (ECM) coating bacilli (B-D, decreasing magnification). The structures of the 5-day old M. chelonae pellicles showed the presence of pores (one such pore is highlighted with a white circle in C).

3.2. Raman spectroscopy reveals differing spectra for M. chelonae biofilms and planktonic cells

To further outline the biomolecular constituents of M. chelonae biofilms, we next queried whether biofilms had distinct biomolecule composition compared to planktonic cultures. We initiated these studies using Raman Spectroscopy (RS). We chose RS as it is a rapid approach to study the overall biochemical composition between biofilms and planktonic bacteria to outline differences between samples. Unlike other vibrational spectroscopic techniques, such as infrared spectroscopy, water does not cause interference, an attribute that makes Raman spectroscopy an attractive tool for studying intact biofilms with minimal processing requirements (Kelestemur et al., 2018). RS has been widely used to study bacterial biofilms (Kelestemur et al., 2018). It has also been used to study the biology of mycobacteria (Buijtels et al., 2008, Kumar et al., 2020, Perumal et al., 2018, Stöckel et al., 2017, Stöckel et al., 2015, Verma et al., 2019). Raman spectroscopy also has potential as a diagnostic tool, as it allows the identification of mycobacteria to the species level (Buijtels et al., 2008, Stöckel et al., 2017, Stöckel et al., 2015, Verma et al., 2019), and even to determine the viability of the identified bacilli (Kumar et al., 2020). We generated the Raman spectra from M. chelonae planktonic, as well as 5 day (Biofilm t1) and 10 day old biofilms (Biofilm t2) (Fig. 2A). While it was not possible to distinguish between samples to easily identify Raman peaks by overlaying the spectra, we were able to observe differences following Principal Component Analysis of the collected spectral data (File S1, supplemental materials). We found that 62.6% of the variance from the data set could be explained using three principal components (PC1 36.3%, PC2 23.6%, and PC3 2.7%), and we further compared the intensities of the signal of characteristics Raman shifts with high contribution to these PCs (File S1, supplemental materials). We then associated the identified Raman shifts with biomolecules using previously described Raman signatures (Kuhar et al., 2018, Talari et al., 2015, Wiercigroch et al., 2017). The analysis showed that the highest variability between M. chelonae planktonic growth and biofilms was for lipids (1400–1500 cm−1, lipids IV) and protein signals (1003 cm−1, phenylalanine; 1200–1300 cm−1, amide III), with a lesser variability for nucleic acids (726 cm−1, adenine; 791 cm−1, pyrimidine; 1099 cm−1, symmetric stretching of PO4- in DNA) and carbohydrates (941 cm−1, α(1 → 6) glycosidic linkage; 1131 cm−1, symmetric stretching in glycosidic linkage) (Fig. 2A, File S1, supplemental materials). For proteins, we observed a decrease in the intensity of characteristics signals in Biofilm t2 (Fig. 2B), whereas the signals for lipids increased (Fig. 2C) in Biofilm t2.

Fig. 2.

Fig. 2

Raman spectra of M. chelonae cultures. Raman spectra was obtained from M. chelonae biofilms and planktonic cultures (Fig. 2A), and the principal component analysis (File S1, supplemental materials) show differences mainly in Raman shifts associated to proteins and lipids. A comparison of the medians of the intensities for characteristic Raman shifts associated with proteins (Fig. 2B; phenylalanine 1003 cm−1 and amide III 1245 cm−1) shows a uniform trend, where the medians of the intensity of the signals decrease for Biofilm t2 compared to Planktonic cultures or Biofilm t1; while the comparison of the intensities of the Raman shifts in regions associated with lipids (Fig. 2C; lipids region IV 1471 cm−1, and Lipids region VI, 864 cm1) are increased in Biofilm t2 compared to Biofilm t1 and Planktonic bacteria (C). The Raman shifts with high contribution to the principal components associated with nucleic acids (ring breathing of adenine, 726 cm1; phosphodiester bonds in DNA,788 cm1; symmetric stretching of PO4 in DNA, 1099 cm−1) and carbohydrates (glycosidic linkage, 1131 cm−1 and 941 cm−1) did not show a uniform trend (File S1, supplemental materials), likely due to the contribution of other biomolecules at the same wavelengths.

3.3. Flourescence confocal microscopy of the M. Chelonae biofilm

To follow up on our findings of a potential ECM structure revealed by SEM of M. chelonae biofilms, and its biomolecular composition by RS analysis, we further studied the composition and architecture of the M. chelonae biofilms using confocal microscopy. While 5-day old biofilms (Biofilm t1) of eGFP-expressing M. chelonae were stained with an array of fluorophores to selectively label the components of the biofilm; 10-day old biofilms (Biofilm t2) were easily disrupted with the washes involved in staining, so imaging was not pursued. We used Nile Red (NR, Sigma Aldrich) for staining lipids, Concanavalin A conjugated with Alexa Fluor 647 (ConcA, Thermo Fisher Scientific) for staining carbohydrate (polysaccharide), FilmTracer™ SYPRO® Ruby biofilm matrix stain (SR, Thermo Fisher Scientific) for proteins, and Propidium Iodide (PI, Sigma Aldrich) for nucleic acids. With the exception of NR, that is a lipophilic molecule able to penetrate mycobacterial cell wall (Xu et al., 2014, Yu et al., 2012), and thus able to stain extracellular and intracellular lipids, M. chelonae is impermeable to all other dyes used for staining. As an example, we used PI to stain eDNA, as this dye is commonly used as a cell viability marker, because it can’t penetrate intact cell membranes. Confocal imaging of the biofilms revealed staining by all four fluorophores indicating the presence of lipids, proteins, carbohydrates and DNA at an extracellular location (Fig. 3). Remarkably, the distribution of some of these biomolecules was not uniform in the biofilm, with some showing ‘sectoring’ with areas of high levels, to sectors where no signal was detected. File S2, supplemental materials, shows binarized images of a confocal stack of eGFP expressing M. chelonae biofilms stained for lipids, carbohydrates, protein, and eDNA, visualised traversing from the bottom to the top of a 20 μm section of the biofilm. To quantify this observation, we then evaluated colocalization between the bacilli and each of the four biopolymers. These measurements helped us to objectively describe the biofilm matrix (Schlafer and Meyer, 2017). To quantitate colocalization, we calculated two sets of values for the fluorescence signals obtained: Pearson’s correlation coefficient and Mander’s coefficients. Pearson’s correlation coefficient allows us to assess how well two signals linearly correlate to each other. The higher the value of the Pearson’s correlation coefficient is, the more likely the intensity of one signal will linearly increase, proportionally to the other signal it is being compared to. For example, if the intensity of the fluorescence signal of one of the biomolecules is compared to that of bacterial cell expressed GFP, and both signals increase or decrease proportionally, there is a correlation of the signal with GFP will be indicated by a high Pearson’s co-efficient. However, if the intensity of the signal from a biomolecule does not change regardless of the amount of bacteria (eGFP signal), the resultant value of the Pearson coefficient is lower. Manders co-efficient on the other hand is a measure of the co-occurrence of two signals, measuring the fraction of a given signal that overlaps with a second signal. If the fluorescence signal of a labelled biomolecule completely overlaps with the bacterial GFP signal, the Manders co-efficient will be 1, while a Mander’s coefficient of 0 means that none of the two signals overlap, i.e. the biomolecule and the bacteria are in distinct, exclusive sectors. We also calculated the relative volume of each of the assessed biopolymer, using as a reference the volume of M. chelonae (eGFP) in the biofilm. All the coefficients are summarized in Table 2. The data indicated that while both eDNA and lipids showed a high level of colocalization with bacteria in the images (Fig. 3), lipids with their relatively lower calculated Mander’s coefficients were more scattered across the biofilm matrix than eDNA. Proteins colocalize well with the bacteria, however, only around the 70% of the signal from proteins overlap with the bacteria (Manders coefficient M2, Table 2), showing that proteins form the bulk component of the biofilm matrix. Finally, the samples stained for carbohydrates showed the lowest Pearson’s coefficient, meaning a weak linear correlation of the intensity of the signals, even though around 90% of the carbohydrate signal overlaps with the signal for the bacilli. This indicated that there are zones in the biofilm that accumulate larger amounts of carbohydrates, mostly in the matrix, compared to the carbohydrates occurring in the close proximity of the bacteria.

Fig. 3.

Fig. 3

Confocal micrographs of 5-day old M. chelonae biofilms. 5-day old eGFP-expressing M. chelonae biofilms were stained separately with fluorophores targeting polymers from the biofilm matrix. Nile red (Fig. 3A) was used to stain lipids, Propidium Iodide (Fig. B) for eDNA, SYPRO Ruby biofilm stain (Fig, 3C) for proteins, and Concanavalin A conjugated with AlexaFluor 647 (Fig. 3D) for carbohydrates. From left to right, 3D projections confocal z-stacks for eGFP, the fluorophore targeting a component from the extracellular matrix, and the overlay of both signals.

Table 2.

Colocalization coefficients for M. chelonae biofilm components.

Component of the ECM Relative volume Pearson’s correlation coefficient Mander’s coefficient
M1 M2
Nile Red (Lipids) 1.030 0.717 0.926 0.898
Propidium iodide (eDNA) 1.081 0.859 0.984 0.924
Concanavalin A Alexa Fluor 647 (Carbohydrates) 0.688 0.271 0.640 0.966
SYPRO Ruby (Proteins) 1.073 0.678 0.832 0.732

3.4. Pellicles of M. chelonae exhibit a different lipid profile compared to planktonic cells

As mycobacteria produce a range of distinctive lipids, and given that several genes related to lipid metabolism are known to play a key role during mycobacterial biofilm formation, we chose to follow up on our microscopy and RS studies, by first looking at the lipid profiles of M. chelonae biofilms. Biofilm or planktonic M. chelonae cultures, were grown in Sauton’s media supplemented with 14C-acetic acid, and the extracted lipid fractions were resolved by thin layer chromatography, and visualized by auto-radiography (Fig. 4). Free mycolic acids were produced in excess by M. chelonae biofilms (Fig. 4A) when compared to those from planktonic cultures (Fig. 4B). Also, trehalose dimycolate (TDM) content decreased from biofilm t1 to biofilm t2 (Fig. 4C and 4D). Both lipid alterations have also been seen in other mycobacterial biofilms (Ojha et al., 2010). However, an alteration in a third class of lipids appeared distinct to M. chelonae biofilms: the amount of phosphatidylglycerol (PG) seems to be increased in M. chelonae biofilms (Fig. 4E) as compared to its planktonic counterpart (Fig. 4F), although this lipid is known to be scarce in the mycobacterial inner membrane (Jackson et al., 2000).

Fig. 4.

Fig. 4

Lipid profile of M. chelonae cultures. Solvent extractable lipid fractions from M. chelonae biofilms and planktonic bacteria were resolved using thin layer chromatography, using solvent systems of different polarities. M. chleonae biofilms (Fig. 4A) show an accumulation of free mycolic acids (FMA) compared to planktonic cultures (Fig. 4B). The amount of trehalose dimycolate (TDM) decreases from biofilm T1 (5 days, Fig. 4C) to biofilm T2 (10 days, Fig. 4D). Polar lipids from M. chelonae biofilm T1 (Fig. 4E) show an accumulation of phosphatidyl glycerol (PG) compared to its planktonic counterpart (Fig. 4F). DAT- diacylthrealose, DPG- diphosphatidyl glycerol, PE- phosphatidyl ethanolamine, PI- phosphatidylinositol, AC2PIM2- diacetylated phosphatidylinositol dimannoside, AC1PIM2- acetylated phosphatidylinositol dimannoside, PIMs- phosphatidylinositol mannosides.

3.5. The glucose content of M. chelonae biofilms decreases as the biofilm ages

To further study the nature of the carbohydrates detected in M. chelonae biofilm ECM by confocal microscopy and RS analysis, we assessed the composition of the polysaccharides present in the ECM. We separated the ECM from biofilm structure, and further purified polysaccharides by mechanically separating the ECM with glass beads, followed by chemical partition and protein digestion, prior dialyzing of the obtained aqueous phase using a 3 kDa membrane to remove salts and other small molecules (from media components). The purified extracts were hydrolysed with TFA to yield monosaccharides, which were in turn derivatized to alditol acetates, and resolved using gas chromatography (GC). The relative abundance of the principal monosaccharide components in the ECM of M. chelonae pellicles is summarized in Fig. 5. We found that the components of extracellular polysaccharides of M. chelonae biofilms, both t1 and t2, and planktonic cultures are glucose, mannose and arabinose; however, glucose stood out as being the most abundant. Interestingly, the proportion of the glucose content in the ECM polysaccharides decreases from biofilm t1 to biofilm t2.

Fig. 5.

Fig. 5

Relative abundance of sugars from extracellular polysaccharides. Polysaccharydes from the ECM of M. chelonae biofilms the three most abundant monosaccharydes present in M. chelonae biofilms and planktonic extracellular material are, in decreasing order, glucose, mannose, and arabinose. The relative abundance of glucose drops in Biofilm t2 compared to Biofilm t1 or planktonic bacteria.

3.6. M. chelonae biofilms display a distinct transcriptional profile

To outline potential molecular mechanisms driving M. chelonae biofilm formation, we performed a transcriptomic analysis (RNA-seq) of M. chleonae biofilm t1 and t2, and compared these to that of a planktonic culture. Over all 293 genes were significantly differentially expressed (P-value < 0.01 and estimated absolute log2 fold-change > 2) in 5-day old biofilms (Biofilm t1), and 633 in 10-day old biofilms (Biofilm t2) (Fig. 6A). Identities of the DEGs are shown in File S3, supplemental materials. A total of 264 of these genes show significant differential expression with same directionality (i.e. up- or down-regulation) in both stages (Fig. 6B). The change in the expression of this set of genes could be due to the bacilli entering into the stationary phase, or perhaps because these genes have a role in biofilm maintenance. To depict an example, among the common genes differentially expressed with the same directionality in both biofilm stages, we found genes from the mce5 operon, and mce1A. In M. tuberculosis the genes from the mce operons are upregulated during the stationary phase (Saini et al., 2008, Singh et al., 2016). In the context of biofilm, the deletion of all six of mce operons in M. smegmatis impairs the formation of this structure, likely due to alterations on the cell wall composition (Klepp et al., 2012). In this study, we found that genes of the mce5 operon (BB28_RS04495/yrbE5A, BB28_RS04475/mce5C, BB28_RS04470/mce5D, and BB28_RS04485/mce5A) are downregulated during both biofilm stages, in contrast to what has been observed during the stationary phase in M. tuberculosis. We also observe an upregulation of the mce1A gene in both biofilm stages. The mce1 operon aids M. tuberculosis to transition better from a slow growth rate state to a fast growth rate state (Beste et al., 2009), a trait that may result beneficial for the bacilli residing in a biofilm. These two examples suggest that, although some transcriptional changes occurring in the stationary phase are common to biofilm formation (upregulation of the mce1A gene), there are specific transcriptional signatures (downregulation of the mce5 operon genes) occurring during biofilm formation.

Fig. 6.

Fig. 6

Differentially expressed genes and enriched metabolic subsystems in M. chelonae biofilms. The Venn diagram for DEGs (Fig. 6A) shows that 293 genes are significantly differentially expressed during Biofilm t1, while 633 are differentially expressed in Biofilm t2. There is a common set of 264 genes that show significant differential expression with the same directionality, and the raw Z-scores of the 240 up-regulated genes (Fig. 6B, green), and the 24 down-regulated genes (Fig. 6B, pink), are shown in the heatmap for biofilm T1 and T2 (Fig. 6B), suggesting a core group of genes required for the maintenance of the biofilm. The list of the enriched metabolic pathways, and their respective fold change, during Biofilm t1 and Biofilm t2 (Fig. 6C and Fig. 6D) shows that seven metabolic pathways are enriched during Biofilm t1, while only four are enriched during Biofilm t2. The genes that are differentially expressed on those metabolic pathways can be found in File S4 in supplemental materials.

To further query the metabolic pathways enriched during biofilm formation, we used a recently updated genome-scale model of Mycobacterium tuberculosis metabolism, iEK1011 (Kavvas et al., 2018), and looked for orthologs within the significantly differentially expressed genes from our transcriptional data. Eight metabolic pathways showed enrichment (Benjamini-Hochberg adjusted P-value < 0.05) in biofilm t1 (Fig. 6C), and four in biofilm t2 (Fig. 6D). The identities of the genes from each metabolic subsystem are summarized in supplemental materials (File S4). Transport genes and those for mycobactin biosynthesis are down-regulated in both biofilm t1 and t2. In addition, during biofilm t2 genes involved in the arginine and proline metabolism were down-regulated. Mycolic acid biosynthesis and other lipid metabolism were up-regulated during biofilm t1, as well as genes from the redox metabolism and glyoxylate pathway. Interestingly, lat (BB28_RS18260), coding for a lysine amino transferase (Tripathi and Ramachandran, 2006), is up-regulated in biofilm t1 and t2. In M. smegmatis, lat is involved in persister cell formation following exposure to norfloxacin (Li et al., 2016).

4. Discussion

Mycobacterium chelonae, like other clinically relevant NTMs, forms biofilms both in the environment and in the host. We have characterized M. chelonae pellicles, an in vitro biofilm model, describing the presence and composition of an ECM in the biofilm. We also delineated distinct transcriptional responses with potential roles in biofilm formation. The mechanisms involved in the development of mycobacterial biofilms are orchestrated as a response of fluctuations of redox state of the bacilli (Geier et al., 2008, Gupta et al., 2015, Koliwer-brandl et al., 2016, Ojha and Hatfull, 2007, Trivedi et al., 2016, Van De et al., 2016, Wolff et al., 2015), which in turn are generated due to the microenvironments within the biofilm. We observe an up-regulation of redox metabolism genes during Biofilm t1, specifically of subunits of the BD cytochrome, used in the electron transfer chain during hypoxic conditions. In M. smegmatis biofilms the NADH/NAD+ ratio is three times higher than in planktonic M. smegmatis (Anand et al., 2015), suggesting a reductive environment in bacilli within biofilms. Mycobacteria can use a variant of the TCA cycle that reduces oxaloacetate to succinyl CoA to replenish the NAD+ pool (Beste et al., 2011), thus helping to maintain the redox homeostasis in mycobacteria. During Biofilm t1, we observe an up-regulation of the lipid, glyoxylate, and mycolic acid metabolism. It would be interesting to measure metabolites associated with the redox state of the bacilli during M. chelonae biofilms, and also query the metabolic pathways active during biofilm formation/dispersion, to further explore potential anti-biofilm strategies.

Recently the molecular events defining the stages during pellicle formation in Mycobacterium smegmatis have been defined (Yang et al., 2017), and the role of lipid metabolism during biofilm formation has been extensively addressed in several mycobacteria (Anand et al., 2015, Nessar et al., 2011, Ojha et al., 2005, Ojha et al., 2010, Ojha et al., 2008, Pacheco et al., 2013, Pang et al., 2012, Recht and Kolter, 2001, Zambrano and Kolter, 2005). Our data shows that similar to other mycobacteria (Ojha et al., 2008, Ojha et al., 2010), M. chelonae biofilms accumulate free mycolic acids, likely from trehalose dimycolate (TDM), suggesting a similar mechanism as in M. smegmatis, where a serine-hydrolase cleaves TDM to yield free mycolic acids (Ojha et al., 2010). Interestingly, the accumulation of free mycolic acids has also been observed in a M. tuberculosis strain lacking Mez, an enzyme involved in the conversion of malate into pyruvate (Basu et al., 2018). Interestingly, biofilms of M. chelonae seem to accumulate phosphatidyl glycerol (PG), an inner membrane polar lipid species present, but not relatively abundant, in planktonic cells.

Our confocal microscopy analysis shows that proteins, and in a minor proportion, carbohydrates, are present in the biofilm matrix. Previous studies have shown that the most abundant component of M. smegmatis and M. phlei pellicles is proteins, and to a lesser degree, carbohydrates (Lemassu et al., 1996b) suggesting similarities between the biofilms of these mycobacterial species, and contrasts with M. tuberculosis (Ortalo-Magne et al., 1995) and M. avium (Lemassu et al., 1996a) biofilms, where the major component is carbohydrates. The composition of the extracted polysaccharide was predominantly glucose suggesting a cellulose or α-glucan polymer, followed by mannose and arabinose, likely from mannans and arabinomannans. Following extraction of exposed polysaccharides from M. chelonae biofilms, we noted a decrease in the glucose content from biofilm t1 to biofilm t2, which is likely to coincide with the dispersal stage of the biofilm. Other biofilm-forming bacteria are known to modulate polysaccharide metabolism as a strategy for biofilm dispersion (McDougald et al., 2012), as it is a crucial structural component of biofilms (Rathinam et al., 2019, Sutherland, 2001). In Pseudomonas aeruginosa, the quorum sensing molecule, N-acylhomoserine lactone, induces a signalling cascade that represses the pel operon and subsequently the synthesis of the Pel polysaccharide, which is abundant in P. aeruginosa biofilms (Ueda and Wood, 2009). Although quorum sensing molecules have not yet been identified in mycobacteria, it is possible that other signals pertaining to the later stages of the biofilm trigger mechanisms that lead to the repression of the synthesis of biofilm components, such as polysaccharides.

Along with lipids, carbohydrates and proteins, extracellular DNA (eDNA) is present in the matrix of several mycobacterial biofilms (Ackart et al., 2014, Rose et al., 2015, Rose and Bermudez, 2016, Trivedi et al., 2016). eDNA mediates the adhesion of bacteria to substrates prior to biofilm formation, and plays a role in the structural maintenance and protection against antimicrobials in several bacterial pathogens (Okshevsky and Meyer, 2015). M. chelonae forms biofilms with abundant eDNA in a keratitis murine model (Aung et al., 2017), and in mycobacteria, eDNA degradation increases the killing effect of some antibiotics, both in vitro and in vivo (Ackart et al., 2014, Aung et al., 2017, Aung et al., 2016, Rose et al., 2015). The pellicles formed by M. chelonae accumulate a significant amount of eDNA, suggesting that this type of biofilm could be used to resemble in vivo biofilms for further studies.

A thorough understanding of clinically relevant mycobacterial biofilms, such as M. chelonae, could contribute to a better understanding about the key components in NTM biofilms required for colonizing different environments within the human host, and would also contribute to a more rational design of therapeutics against NTM infections driven by biofilms. Our studies highlight the utility of Raman Spectroscopy and fluorescence, confocal microscopy to study the architecture and composition of M. chelonae biofilms. Additionally, the outlining of distinct gene expression patterns in M. chelonae pellicles enables us to conduct further studies on the mechanisms of M. chelonae biofilm formation.

CRediT authorship contribution statement

Perla Vega-Dominguez: Conceptualization, Investigation, Visualization, Validation, Methodology, Formal analysis, Writing - original draft, Writing - review & editing. Eliza Peterson: Conceptualization, Investigation, Visualization, Validation, Methodology, Formal analysis, Writing - original draft, Writing - review & editing. Min Pan: Investigation, Validation, Methodology. Alessandro Di Maio: Methodology, Formal analysis, Writing - review & editing. Saumya Singh: Investigation, Methodology, Formal analysis, Writing - review & editing. Siva Umapathy: Conceptualization, Writing - review & editing. Deepak K. Saini: Conceptualization, Writing - review & editing. Nitin Baliga: Conceptualization, Writing - review & editing. Apoorva Bhatt: Conceptualization, Writing - original draft, Writing - review & editing.

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Acknowledgments

PV-D acknowledges support from the Consejo Nacional de Ciencia y Tecnologia (CONACYT) Mexico for a PhD Scholarship (411092). AB acknowledges funding from the Medical Research Council (MR/S000542/1). EP and NSB acknowledge funding provided by the National Science Foundation, USA (1518261). AB, DS and SU thank the UK-India Education and Research Initiative (UKIERI) for collaborative research exchanges that facilitated the Raman Spectroscopy experiments. We also thank Laurent Kremer for providing the plasmid pMV306eGFP.

Footnotes

Appendix A

Supplementary data to this article can be found online at https://doi.org/10.1016/j.tcsw.2020.100043.

Appendix A. Supplementary data

The following are the Supplementary data to this article:

Supplementary data 1
mmc1.xlsx (259.6KB, xlsx)
Supplementary data 2
mmc2.pptx (5.8MB, pptx)
Supplementary data 3
mmc3.xlsx (119.1KB, xlsx)
Supplementary data 4
mmc4.docx (14.4KB, docx)

References

  1. Ackart D.F., Hascall-Dove L., Caceres S.M., Kirk N.M., Podell B.K., Melander C. Expression of antimicrobial drug tolerance by attached communities of Mycobacterium tuberculosis. Pathog Dis. 2014 doi: 10.1111/2049-632X.12144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Anand A., Verma P., Singh A.K., Kaushik S., Pandey R., Shi C. Polyketide quinones are alternate intermediate electron carriers during mycobacterial respiration in oxygen-deficient niches. Mol. Cell. 2015;60:637–650. doi: 10.1016/j.molcel.2015.10.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Aung T.T., Chor W.H.J., Yam J.K.H., Givskov M., Yang L., Beuerman R.W. Discovery of novel antimycobacterial drug therapy in biofilm of pathogenic nontuberculous mycobacterial keratitis. Ocul Surf. 2017:1–14. doi: 10.1016/j.jtos.2017.06.002. [DOI] [PubMed] [Google Scholar]
  4. Aung T.T., Kuok J., Yam H., Lin S., Salleh S.M., Givskov M. Biofilms of pathogenic nontuberculous mycobacteria targeted by new therapeutic approaches. Antimicrob. Agents Chemother. 2016;60:24–35. doi: 10.1128/AAC.01509-15.Address. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bardouniotis E., Huddleston W., Ceri H., Olson M.E. Characterization of biofilm growth and biocide susceptibility testing of Mycobacterium phlei using the MBECTM assay system. FEMS Microbiol. Lett. 2001;203:263–267. doi: 10.1016/S0378-1097(01)00364-0. [DOI] [PubMed] [Google Scholar]
  6. Basu P., Sandhu N., Bhatt A., Singh A., Balhana R., Gobe I. The anaplerotic node is essential for the intracellular survival of Mycobacterium tuberculosis. J. Biol. Chem. 2018;293:5695–5704. doi: 10.1074/jbc.RA118.001839. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Benwill JL, Wallace RJ. Infections due to nontuberculous mycobacteria. Infect Cent Nerv Syst Fourth Ed 2014;03756.
  8. Besra G.S. Preparation of cell-wall fractions from mycobacteria. Methods Mol. Biol. 1998;101:91–107. doi: 10.1385/0-89603-471-2:91. [DOI] [PubMed] [Google Scholar]
  9. Beste, D.J.V., Bonde, B., Hawkins, N., Ward, J.L., Beale, M.H., Noack, S., et al. 13C Metabolic Flux Analysis Identifies an Unusual Route for Pyruvate Dissimilation in Mycobacteria Which Requires Isocitrate Lyase and Carbon Dioxide Fixation. PLoS Pathog 2011;7. https://doi.org/10.1371/journal.ppat.1002091. [DOI] [PMC free article] [PubMed]
  10. Beste D.J.V., Espasa M., Bonde B., Kierzek A.M., Stewart G.R., McFadden J. The genetic requirements for fast and slow growth in mycobacteria. PLoS ONE. 2009;4. doi: 10.1371/journal.pone.0005349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Bottai D., Stinear T.P., Supply P., Brosch R. Mycobacterial pathogenomics and evolution. Microbiol Spectr. 2014;2:1–19. doi: 10.1128/microbiolspec.mgm2-0025-2013. [DOI] [PubMed] [Google Scholar]
  12. Breitling R., Armengaud P., Amtmann A., Herzyk P. Rank products: A simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments. FEBS Lett. 2004;573:83–92. doi: 10.1016/j.febslet.2004.07.055. [DOI] [PubMed] [Google Scholar]
  13. Brown-Elliott, B.A., Nash, K.A., Wallace, R.J. Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria. Clin Microbiol Rev 2012;25:545–82. https://doi.org/10.1128/CMR.05030-11. [DOI] [PMC free article] [PubMed]
  14. Buijtels P.C.A.M., Willemse-Erix H.F.M., Petit P.L.C., Endtz H.P., Puppels G.J., Verbrugh H.A. Rapid Identification of Mycobacteria by Raman Spectroscopy. J. Clin. Microbiol. 2008;46:961–965. doi: 10.1128/JCM.01763-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Campbell S.M., Winkelmann R.R., Sammons D.L. Erythema induratum caused by Mycobacterium chelonei in an immunocompetent patient. J Clin Aesthet Dermatol. 2013;6:38–40. [PMC free article] [PubMed] [Google Scholar]
  16. Chakraborty P, Kumar A. The extracellular matrix of mycobacterial biofilms: could we shorten the treatment of mycobacterial infections? Microb Cell 2019;6:105–22. https://doi.org/10.15698/mic2019.02.667. [DOI] [PMC free article] [PubMed]
  17. Chandra NS, Torres MF, Winthrop KL, Bruckner DA, Heidemann DG, Calvet HM, et al. Cluster of Mycobacterium Chelonae Keratitis Cases Following Laser In-situ Keratomileusis. Am J Ophthalmol 2001:819–30. https://doi.org/0002-9394/01/$20.00. [DOI] [PubMed]
  18. de Chaumont F., Dallongeville S., Chenouard N., Hervé N., Pop S., Provoost T. Icy: an open bioimage informatics platform for extended reproducible research. Nat. Methods. 2012;9:690–696. doi: 10.1038/nmeth.2075. [DOI] [PubMed] [Google Scholar]
  19. Corti M., Palmero D.J. Mycobacterium avium complex infection in HIV/AIDS patients. Expert Rev Anti Infect Ther. 2008;6:351–363. doi: 10.1586/14787210.6.3.351. [DOI] [PubMed] [Google Scholar]
  20. Cowman S., Burns K., Benson S., Wilson R., Loebinger M.R. The antimicrobial susceptibility of non-tuberculous mycobacteria. J. Infect. 2016;72:324–331. doi: 10.1016/j.jinf.2015.12.007. [DOI] [PubMed] [Google Scholar]
  21. Davidson LB, Nessar R, Kempaiah P, Perkins DJ, Byrd TF. Mycobacterium abscessus Glycopeptidolipid Prevents Respiratory Epithelial TLR2 Signaling as Measured by H b D2 Gene Expression and IL-8 Release. PLoS One 2011;6. https://doi.org/10.1371/journal.pone.0029148. [DOI] [PMC free article] [PubMed]
  22. Falkinham J.O. Ecology of nontuberculous mycobacteria-where do human infections come from? Semin Respir Crit Care Med. 2013;34:95–102. doi: 10.1055/s-0033-1333568. [DOI] [PubMed] [Google Scholar]
  23. Falkinham J.O. Surrounded by mycobacteria: Nontuberculous mycobacteria in the human environment. J. Appl. Microbiol. 2009;107:356–367. doi: 10.1111/j.1365-2672.2009.04161.x. [DOI] [PubMed] [Google Scholar]
  24. Faria S., Joao I., Jordao L. General Overview on Nontuberculous Mycobacteria, Biofilms, and Human Infection. J Pathog. 2015;2015:1–10. doi: 10.1155/2015/809014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Fedrizzi T., Meehan C.J., Grottola A., Giacobazzi E., Fregni Serpini G., Tagliazucchi S. Genomic characterization of Nontuberculous Mycobacteria. Sci. Rep. 2017;7:1–14. doi: 10.1038/srep45258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Freeman R, Geier H, Weigel KM, Do J, Ford TE, Cangelosi G a. Roles for cell wall glycopeptidolipid in surface adherence and planktonic dispersal of Mycobacterium avium. Appl Environ Microbiol 2006;72:7554–8. https://doi.org/10.1128/AEM.01633-06. [DOI] [PMC free article] [PubMed]
  27. Garcia P.K., Annamalai T., Wang W., Bell R.S., Le D., Martin Pancorbo P. Mechanism and resistance for antimycobacterial activity of a fluoroquinophenoxazine compound. PLoS ONE. 2019;14 doi: 10.1371/journal.pone.0207733. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Geier H., Mostowy S., Cangelosi G.A., Behr M.A., Ford T.E. Autoinducer-2 triggers the oxidative stress response in Mycobacterium avium, leading to biofilm formation. Appl. Environ. Microbiol. 2008;74:1798–1804. doi: 10.1128/AEM.02066-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Gilbert J.A. Nosocomial nontuberculous mycobacteria infections associated with heater-cooler devices. Lancet Respir Med. 2017;5:384. doi: 10.1016/S2213-2600(17)30109-1. [DOI] [PubMed] [Google Scholar]
  30. De Groote M.A., Pace N.R., Fulton K., Falkinham J.O. Relationships between Mycobacterium isolates from patients with pulmonary mycobacterial infection and potting soils. Appl. Environ. Microbiol. 2006;72:7602–7606. doi: 10.1128/AEM.00930-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Grzegorzewicz AE, Jackson M. Subfractionation and Analysis of the Cell Envelope (Lipo)polysaccharides of Mycobacterium tuberculosis. Science (80-.)., vol. 214, 2013, p. 309–24. https://doi.org/10.1007/978-1-62703-245-2_19. [DOI] [PMC free article] [PubMed]
  32. Gupta K.R., Kasetty S., Chatterji D. Novel Functions of (p)ppGpp and Cyclic di-GMP in Mycobacterial Physiology Revealed by Phenotype Microarray Analysis of Wild-Type and Isogenic Strains of Mycobacterium smegmatis. Appl. Environ. Microbiol. 2015;81:2571–2578. doi: 10.1128/AEM.03999-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Hall-Stoodley L., Keevil C.W., Lappin-Scott H.M. Mycobacterium fortuitum and Mycobacterium chelonae biofilm formation under high and low nutrient conditions. J. Appl. Microbiol. 1999;85(Suppl 1):60S–69S. doi: 10.1111/j.1365-2672.1998.tb05284.x. [DOI] [PubMed] [Google Scholar]
  34. Henikoff S., Henikoff J.G. Amino acid substitution matrices from protein blocks. Proc Natl Acad Sci U S A. 1992;89:10915–10919. doi: 10.1073/pnas.89.22.10915. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Holland S.P., Pulido J.S., Miller D., Ellis B., Alfonso E., Scott M. Biofilm and Scleral Buckle-associated Infections. Ophthalmology. 2017;98:933–938. doi: 10.1016/S0161-6420(91)32199-7. [DOI] [PubMed] [Google Scholar]
  36. Iivanainen E., Sallantaus T., Katila M.-L., Martikainen P.J. Mycobacteria in Runoff Waters from Natural and Drained Peatlands. J. Environ. Qual. 2010;28:1226. doi: 10.2134/jeq1999.00472425002800040025x. [DOI] [Google Scholar]
  37. Jackson M., Crick D.C., Brennan P.J. Phosphatidylinositol is an essential phospholipid of mycobacteria. J. Biol. Chem. 2000;275:30092–30099. doi: 10.1074/jbc.M004658200. [DOI] [PubMed] [Google Scholar]
  38. Jagadeesan N., Patra S., Singh A.P., Nagesh C.M., Reddy B., Badnur S.C. Spontaneous endocarditis caused by rapidly growing non-tuberculous Mycobacterium chelonae in an immunocompetent patient with rheumatic heart disease. J Cardiovasc Dis Res. 2013;4:254–256. doi: 10.1016/j.jcdr.2013.06.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Jeon D. Infection source and epidemiology of nontuberculous mycobacterial lung disease. Tuberc Respir Dis (Seoul) 2019;82:94–101. doi: 10.4046/trd.2018.0026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Jönsson B.E., Gilljam M., Lindblad A., Ridell M., Wold A.E., Welinder-Olsson C. Molecular epidemiology of Mycobacterium abscessus, with focus on cystic fibrosis. J. Clin. Microbiol. 2007;45:1497–1504. doi: 10.1128/JCM.02592-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Kavvas ES, Seif Y, Yurkovich JT, Norsigian C, Poudel S, Greenwald WW, et al. Updated and standardized genome-scale reconstruction of Mycobacterium tuberculosis H37Rv , iEK1011 , simulates flux states indicative of physiological conditions 2018:1–15. [DOI] [PMC free article] [PubMed]
  42. Kelestemur S., Avci E., Culha M. Raman and Surface-Enhanced Raman Scattering for Biofilm Characterization. Chemosensors. 2018;6:5. doi: 10.3390/chemosensors6010005. [DOI] [Google Scholar]
  43. Kheir W.J., Sheheitli H., Abdul Fattah M., Hamam R.N. Nontuberculous Mycobacterial Ocular Infections: A Systematic Review of the Literature. Biomed Res. Int. 2015;2015:1–17. doi: 10.1155/2015/164989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Klepp L.I., Forrellad M.A., Osella A.V., Blanco F.C., Stella E.J., Bianco M.V. Impact of the deletion of the six mce operons in Mycobacterium smegmatis. Microbes Infect. 2012;14:590–599. doi: 10.1016/j.micinf.2012.01.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Koliwer-brandl H, Syson K, Weerd R Van De, Chandra G, Geurtsen J, Bornemann S, et al. Metabolic Network for the Biosynthesis of Intra- and Extracellular α -Glucans Required for Virulence of Mycobacterium tuberculosis 2016:1–26. https://doi.org/10.1371/journal.ppat.1005768. [DOI] [PMC free article] [PubMed]
  46. Kuhar N., Sil S., Verma T., Umapathy S. Challenges in application of Raman spectroscopy to biology and materials. R Soc Chem. 2018;8:25888–25908. doi: 10.1039/c8ra04491k. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Kumar S., Gopinathan R., Chandra G.K., Umapathy S., Saini D.K. Rapid detection of bacterial infection and viability assessment with high specificity and sensitivity using Raman microspectroscopy. Anal. Bioanal. Chem. 2020;412:2505–2516. doi: 10.1007/s00216-020-02474-2. [DOI] [PubMed] [Google Scholar]
  48. Kwon H.H., Tomioka H., Saito H. Distribution and characterization of β-lactamases of mycobacteria and related organisms. Tuber. Lung Dis. 1995;76:141–148. doi: 10.1016/0962-8479(95)90557-X. [DOI] [PubMed] [Google Scholar]
  49. Langmead B., Salzberg S.L. Fast gapped-read alignment with Bowtie 2. Nat. Methods. 2012;9:357–359. doi: 10.1038/nmeth.1923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Lemassu A., Ortalo-magne A., Bardou F., Silve G. Extracellular and surface-exposed polysaccharides of non-tuberculous mycobacteria. Microbiology. 1996:1513–1520. doi: 10.1099/13500872-142-6-1513. [DOI] [PubMed] [Google Scholar]
  51. Lemassu A., Ortalo-Magné A., Bardou F., Silve G., Lanéelle M.A., Daffé M. Extracellular and surface-exposed polysaccharides of non-tuberculous mycobacteria. Microbiology. 1996;142:1513–1520. doi: 10.1099/13500872-142-6-1513. [DOI] [PubMed] [Google Scholar]
  52. Li C.H., Tam P.K.S. An iterative algorithm for minimum cross entropy thresholding. Pattern Recogn. Lett. 1998;19:771–776. doi: 10.1016/S0167-8655(98)00057-9. [DOI] [Google Scholar]
  53. Li Y., Duan X., Huang Q., Liu Z., Xu M., Guo S. Mycobacterium Lysine ε-aminotransferase is a novel alarmone metabolism related persister gene via dysregulating the intracellular amino acid level. Sci. Rep. 2016;6:1–10. doi: 10.1038/srep19695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Love M.I., Huber W., Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:1–21. doi: 10.1186/s13059-014-0550-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Marsollier L., Brodin P., Jackson M., Korduláková J., Tafelmeyer P., Carbonnelle E. Impact of Mycobacterium ulcerans biofilm on transmissibility to ecological niches and Buruli ulcer pathogenesis. PLoS Pathog. 2007;3 doi: 10.1371/journal.ppat.0030062. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Martín-de-Hijas NZ, García-Almeida D, Ayala G, Fernández-Roblas R, Gadea I, Celdrán a, et al. Biofilm development by clinical strains of non-pigmented rapidly growing mycobacteria. Clin Microbiol Infect 2009;15:931–6. https://doi.org/10.1111/j.1469-0691.2009.02882.x. [DOI] [PubMed]
  57. McDougald D., Rice S.A., Barraud N., Steinberg P.D., Kjelleberg S. Should we stay or should we go: Mechanisms and ecological consequences for biofilm dispersal. Nat. Rev. Microbiol. 2012;10:39–50. doi: 10.1038/nrmicro2695. [DOI] [PubMed] [Google Scholar]
  58. Nessar R., Reyrat J.-M., Davidson L.B., Byrd T.F. Deletion of the mmpL4b gene in the Mycobacterium abscessus glycopeptidolipid biosynthetic pathway results in loss of surface colonization capability, but enhanced ability to replicate in human macrophages and stimulate their innate immune response. Microbiology. 2011;157:1187–1195. doi: 10.1099/mic.0.046557-0. [DOI] [PubMed] [Google Scholar]
  59. Ojha A., Anand M., Bhatt A., Kremer L., Jacobs W.R., Hatfull G.F. GroEL1: a dedicated chaperone involved in mycolic acid biosynthesis during biofilm formation in mycobacteria. Cell. 2005;123:861–873. doi: 10.1016/j.cell.2005.09.012. [DOI] [PubMed] [Google Scholar]
  60. Ojha A., Hatfull G.F. The role of iron in Mycobacterium smegmatis biofilm formation: The exochelin siderophore is essential in limiting iron conditions for biofilm formation but not for planktonic growth. Mol. Microbiol. 2007;66:468–483. doi: 10.1111/j.1365-2958.2007.05935.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Ojha A.K., Baughn A.D., Sambandan D., Hsu T., Trivelli X., Guerardel Y. Growth of Mycobacterium tuberculosis biofilms containing free mycolic acids and harbouring drug-tolerant bacteria. Mol. Microbiol. 2008;69:164–174. doi: 10.1111/j.1365-2958.2008.06274.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Ojha A.K., Trivelli X., Guerardel Y., Kremer L., Hatfull G.F. Enzymatic hydrolysis of trehalose dimycolate releases free mycolic acids during mycobacterial growth in biofilms. J. Biol. Chem. 2010;285:17380–17389. doi: 10.1074/jbc.M110.112813. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Okshevsky M., Meyer R.L. The role of extracellular DNA in the establishment, maintenance and perpetuation of bacterial biofilms. Crit. Rev. Microbiol. 2015;41:341–352. doi: 10.3109/1040841X.2013.841639. [DOI] [PubMed] [Google Scholar]
  64. Orme I.M., Ordway D.J. Host Response to Nontuberculous Mycobacterial Infections of Current Clinical Importance. Infect. Immun. 2014;82:3516–3522. doi: 10.1128/IAI.01606-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Ortalo-Magne A., Dupont M.A., Lemassu A., Andersen A.B., Gounon P., Daffe M. Molecular composition of the outermost capsular material of the tubercle bacillus. Microbiology. 1995;141:1609–1620. doi: 10.1099/13500872-141-7-1609. [DOI] [PubMed] [Google Scholar]
  66. Pacheco S a., Hsu FF, Powers KM, Purdy GE. MmpL11 protein transports mycolic acid-containing lipids to the mycobacterial cell wall and contributes to biofilm formation in Mycobacterium smegmatis. J Biol Chem 2013;288:24213–22. https://doi.org/10.1074/jbc.M113.473371. [DOI] [PMC free article] [PubMed]
  67. Pang J.M., Layre E., Sweet L., Sherrid A., Moody D.B., Ojha A. The polyketide Pks1 contributes to biofilm formation in Mycobacterium tuberculosis. J. Bacteriol. 2012;194:715–721. doi: 10.1128/JB.06304-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Parish T., Stoker N.G., Daffé M., Lanéelle M.-A. Analysis of the Capsule of Mycobacterium tuberculosis. Mycobacterium Tuberc Protoc. 2003;54:217–227. doi: 10.1385/1-59259-147-7:217. [DOI] [Google Scholar]
  69. Pedregosa F., Varoquaux G., Gramfort A., Michel V., Thirion B., Grisel O. Scikit-learn: Machine Learning in Python Fabian. J OfMachine Learn Res. 2011;12:2825–2830. doi: 10.1145/2786984.2786995. [DOI] [Google Scholar]
  70. Perumal J., Dinish U., Bendt A.K., Kazakeviciute A., Yaw Fu.C., Hao Ong I.L. Identification of mycolic acid forms using surface-enhanced Raman scattering as a fast detection method for tuberculosis. Int J Nanomedicine. 2018;13:6029–6038. doi: 10.2147/IJN.S171400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Pike J.A., Styles I.B., Rappoport J.Z., Heath J.K. Quantifying receptor trafficking and colocalization with confocal microscopy. Methods. 2017;115:42–54. doi: 10.1016/j.ymeth.2017.01.005. [DOI] [PubMed] [Google Scholar]
  72. Qvist T, Eickhardt-Sørensen S, Pressler T, Katzenstein TL, Andersen CB, Iversen M, et al. First evidence of Mycobacterium abscessus biofilm in the lungs of chronically infected CF patients. JCystFibros 2013;12:S2–S2. https://doi.org/10.1016/S1569-1993(13)60006-5.
  73. Qvist T., Eickhardt S., Kragh K.N., Andersen C.B., Iversen M., Høiby N. Chronic pulmonary disease with Mycobacterium abscessus complex is a biofilm infection. Eur. Respir. J. 2015;46:1823–1826. doi: 10.1183/13993003.01102-2015. [DOI] [PubMed] [Google Scholar]
  74. Rathinam N.K., Sani R.K., Gupta P., Pruthi P.A., Pruthi V. Role of Exopolysaccharides in Biofilm Formation. ACS Symp. Ser. 2019;1323:17–57. doi: 10.1021/bk-2019-1323.ch002. [DOI] [Google Scholar]
  75. Recht J., Kolter R. Glycopeptidolipid acetylation affects sliding motility and biofilm formation in Mycobacterium smegmatis. J. Bacteriol. 2001;183:5718–5724. doi: 10.1128/JB.183.19.5718-5724.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Rhoades ER, Archambault AS, Hsu F, Streeter C, Thomas F, Rhoades ER, et al. Mycobacterium abscessus Glycopeptidolipids mask underlying cell wall phosphatidyl-myo-inositol mannosides blocking induction of human macrophage TNF-alpha by preventing interaction with TLR2. J Immunol 2019;183:1997–2007. https://doi.org/https://doi.org/10.4049/jimmunol.0802181. [DOI] [PubMed]
  77. Robinson M.D., Smyth G.K. Small-sample estimation of negative binomial dispersion, with applications to SAGE data. Biostatistics. 2008;9:321–332. doi: 10.1093/biostatistics/kxm030. [DOI] [PubMed] [Google Scholar]
  78. Rose S.J., Babrak L.M., Bermudez L.E. Mycobacterium avium Possesses Extracellular DNA that Contributes to Biofilm Formation, Structural Integrity, and Tolerance to Antibiotics. PLoS ONE. 2015;10 doi: 10.1371/journal.pone.0128772. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Rose S.J., Bermudez L.E. Identification of Bicarbonate as a Trigger and Genes Involved with Extracellular DNA Export in Mycobacterial Biofilms. MBio. 2016;7:e01597–e1616. doi: 10.1128/mBio.01597-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Roux A.-L., Viljoen A., Bah A., Simeone R., Bernut A., Laencina L. The distinct fate of smooth and rough Mycobacterium abscessus variants inside macrophages. Open Biol. 2016;6 doi: 10.1098/rsob.160185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Saini N.K., Sharma M., Chandolia A., Pasricha R., Brahmachari V., Bose M. Characterization of Mce4A protein of Mycobacterium tuberculosis: Role in invasion and survival. BMC Microbiol. 2008;8:1–8. doi: 10.1186/1471-2180-8-200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Sambandan D., Dao D.N., Weinrick B.C., Vilchèze C., Gurcha S.S., Ojha A. Keto-Mycolic acid-dependent pellicle formation confers tolerance to drug-sensitive Mycobacterium tuberculosis. MBio. 2013;4:1–10. doi: 10.1128/mBio.00222-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Schlafer S., Meyer R.L. Confocal microscopy imaging of the biofilm matrix. J. Microbiol. Methods. 2017;138:50–59. doi: 10.1016/j.mimet.2016.03.002. [DOI] [PubMed] [Google Scholar]
  84. Schreiber P.W., Köhler N., Cervera R., Hasse B., Sax H., Keller P.M. Detection limit of Mycobacterium chimaera in water samples for monitoring medical device safety: insights from a pilot experimental series. J. Hosp. Infect. 2018;99:284–289. doi: 10.1016/j.jhin.2017.11.007. [DOI] [PubMed] [Google Scholar]
  85. Singh P., Katoch V., Mohanty K., Chauhan D. Analysis of expression profile of mce operon genes (mce1, mce2, mce3 operon) in different Mycobacterium tuberculosis isolates at different growth phases. Indian J. Med. Res. 2016;143:487. doi: 10.4103/0971-5916.184305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Stöckel S., Meisel S., Lorenz B., Kloß S., Henk S., Dees S. Raman spectroscopic identification of Mycobacterium tuberculosis. J. Biophotonics. 2017;10:727–734. doi: 10.1002/jbio.201600174. [DOI] [PubMed] [Google Scholar]
  87. Stöckel S., Stanca A.S., Helbig J., Rösch P., Popp J. Raman spectroscopic monitoring of the growth of pigmented and non-pigmented mycobacteria. Anal. Bioanal. Chem. 2015;407:8919–8923. doi: 10.1007/s00216-015-9031-5. [DOI] [PubMed] [Google Scholar]
  88. Sutherland I.W. Biofilm exopolysaccharides: A strong and sticky framework. Microbiology. 2001;147:3–9. doi: 10.1099/00221287-147-1-3. [DOI] [PubMed] [Google Scholar]
  89. Svetlíková Z., Škovierová H., Niederweis M., Gaillard J.L., McDonnell G., Jackson M. Role of porins in the susceptibility of Mycobacterium smegmatis and Mycobacterium chelonae to aldehyde-based disinfectants and drugs. Antimicrob. Agents Chemother. 2009;53:4015–4018. doi: 10.1128/AAC.00590-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Talari A.C.S., Movasaghi Z., Rehman S., Rehman I.U. Raman spectroscopy of biological tissues. Appl. Spectrosc. Rev. 2015;50:46–111. doi: 10.1080/05704928.2014.923902. [DOI] [Google Scholar]
  91. Tripathi S.M., Ramachandran R. Overexpression, purification and crystallization of lysine ε-aminotransferase (Rv3290c) from Mycobacterium tuberculosis H37Rv. Acta Crystallogr., Sect. F: Struct. Biol. Cryst. Commun. 2006;62:572–575. doi: 10.1107/S1744309106016824. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Trivedi A., Mavi P.S., Bhatt D., Kumar A. Thiol reductive stress induces cellulose-anchored biofilm formation in Mycobacterium tuberculosis. Nat. Commun. 2016;7:11392. doi: 10.1038/ncomms11392. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Tusher V.G., Tibshirani R., Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A. 2001;98:5116–5121. doi: 10.1073/pnas.091062498. [DOI] [PMC free article] [PubMed] [Google Scholar]
  94. Ueda A., Wood T.K. Connecting quorum sensing, c-di-GMP, pel polysaccharide, and biofilm formation in Pseudomonas aeruginosa through tyrosine phosphatase TpbA (PA3885) PLoS Pathog. 2009;5:1–15. doi: 10.1371/journal.ppat.1000483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Verma T., Podder S., Mehta M., Singh S., Singh A., Umapathy S. Raman spectroscopy reveals distinct differences between two closely related bacterial strains, Mycobacterium indicus pranii and Mycobacterium intracellulare. Anal. Bioanal. Chem. 2019;411:7997–8009. doi: 10.1007/s00216-019-02197-z. [DOI] [PubMed] [Google Scholar]
  96. Vignali M., Armour C., Chen J., Morrison R., Castle J., Biery M. NSR-seq transcriptional profiling enables identification of a gene signature of Plasmodium falciparum parasites infecting children. J Clin Invest. 2011;121:1119–1129. doi: 10.1172/JCI43457DS1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. Van De Weerd R, Boot M., Maaskant J., Sparrius M., Verboom T., Van Leeuwen LM. Inorganic Phosphate Limitation Modulates Capsular Polysaccharide Composition in Mycobacteria. J. Biol. Chem. 2016;291:11787–11799. doi: 10.1074/jbc.M116.722454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Wiercigroch E., Szafraniec E., Czamara K., Pacia M.Z., Majzner K., Kochan K. Raman and infrared spectroscopy of carbohydrates: A review. Spectrochim Acta - Part A Mol Biomol Spectrosc. 2017;185:317–335. doi: 10.1016/j.saa.2017.05.045. [DOI] [PubMed] [Google Scholar]
  99. Wolff K.A., de la Peña A.H., Nguyen H.T., Pham T.H., Amzel L.M., Gabelli S.B. A Redox Regulatory System Critical for Mycobacterial Survival in Macrophages and Biofilm Development. PLoS Pathog. 2015;11:1–20. doi: 10.1371/journal.ppat.1004839. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Xu W.X., Zhang L., Mai J.T., Peng R.C., Yang E.Z., Peng C. The Wag31 protein interacts with AccA3 and coordinates cell wall lipid permeability and lipophilic drug resistance in Mycobacterium smegmatis. Biochem. Biophys. Res. Commun. 2014;448:255–260. doi: 10.1016/j.bbrc.2014.04.116. [DOI] [PubMed] [Google Scholar]
  101. Yang Y., Thomas J., Li Y., Vilchèze C., Derbyshire K.M., Jacobs W.R. Defining a temporal order of genetic requirements for development of mycobacterial biofilms. Mol. Microbiol. 2017;105:794–809. doi: 10.1111/mmi.13734. [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. Yu J., Tran V., Li M., Huang X., Niu C., Wang D. Both Phthiocerol Dimycocerosates and Phenolic Glycolipids Are Required for Virulence of Mycobacterium marinum. Infect. Immun. 2012;80:1381–1389. doi: 10.1128/IAI.06370-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. Zambrano M.M., Kolter R. Mycobacterial biofilms: a greasy way to hold it together. Cell. 2005;123:762–764. doi: 10.1016/j.cell.2005.11.011. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary data 1
mmc1.xlsx (259.6KB, xlsx)
Supplementary data 2
mmc2.pptx (5.8MB, pptx)
Supplementary data 3
mmc3.xlsx (119.1KB, xlsx)
Supplementary data 4
mmc4.docx (14.4KB, docx)

Articles from The Cell Surface are provided here courtesy of Elsevier

RESOURCES